Status:
TERMINATED
Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine
Lead Sponsor:
Bandim Health Project
Collaborating Sponsors:
International Cooperation with Developing Countries
Leiden University Medical Centre, DEPT of Parasitology, Leiden Holland
Conditions:
Malaria
Eligibility:
All Genders
19-24 years
Phase:
PHASE4
Brief Summary
BCG has marked immune stimulatory effects in both animal and human studies and observational studies suggest that BCG is associated with a non-specific reduction in mortality in areas with high infant...
Detailed Description
Examine in a randomised trial whether revaccination with BCG reduces childhood mortality after 19 months of age by 30%. Criteria for verification: 3,000 children aged 1½ year enrolled and followed fo...
Eligibility Criteria
Inclusion
- No overt illness
Exclusion
- PPD reaction \>15mm
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
2871 Patients enrolled
Trial Details
Trial ID
NCT00126217
Start Date
July 1 2002
End Date
September 1 2006
Last Update
October 21 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Apartado 861, Bissau, Guinea-Bissau